Crossref

1. Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment

- Renyong Guo

- Hejun Mao

- Xiao Hu

- Nengneng Zheng

- Dong Yan

- Jianqin He

- Jiezuan Yang

2. Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment

- Xiaoling Yang

- Jia Li

- Jie Liu

- Min Gao

- Li Zhou

- Wei Lu

3. Role of Tim-3 in hepatitis B virus infection: An overview

- Yuan Liu

- Li-Fen Gao

- Xiao-Hong Liang

- Chun-Hong Ma

4. The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics

- Upkar S. Gill

- Patrick T. F. Kennedy

5. FoxP3, PD-1 and CTLA-4 are Decreased Significantly After a Tenofovir Therapy in Patients With Chronic Hepatitis B

- Hyosun Cho

- Hyojeung Kang

- Ji Y Kim

- Hee Y Kim

- Chang W Kim

6. Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue

- Li-Li Wu

- Xiao-Yan Li

- Kai Deng

- Bing-Liang Lin

- Hong Deng

- Dong-Ying Xie

- Geng-Lin Zhang

- Qi-Yi Zhao

- Zhi-Shuo Mo

- Yue-Hua Huang

- Zhi-Liang Gao

7. The Influences of Antiviral Therapy on T-cell Function in Adult Patients with Chronic Hepatitis B

- Soeradj Harkisoen

- Steven Kroon

- Karel J van Erpecum

- Andy IM Hoepelman

- Debbie van Baarle

- Joop E Arends

8.

9. Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate

- Darmadi Darmadi

- Dharma Lindarto

- Jelita Siregar

- Tri Widyawati

- Muhammad Rusda

- Mustafa Mahmud Amin

- Fauzi Yusuf

- Putri Chairani Eyanoer

- Masrul Lubis

- Imelda Rey

10. Interleukin-35 modulates the balance between viral specific CD4+CD25+CD127dim/- regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection

- Lanlan Yang

- Shengnan Jia

- Xue Shao

- Siqi Liu

- Qian Zhang

- Jie Song

- Wudong Wang

- Zhenjing Jin

11. Circulating IL-1β, IL-17, and IP-10 as Potential Predictors of Hepatitis B Virus Infection Prognosis

- Zhenzhen Su

- Jie Chen

- Junlong Zhang

- Yunfei An

- Yun Liao

- Xiaojuan Wu

- Chuanmin Tao

- Lanlan Wang

- Bei Cai

- Dawei Cui

12. Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate

- Darmadi Darmadi

- Dharma Lindarto

- Jelita Siregar

- Tri Widyawati

- Muhammad Rusda

- Mustafa Mahmud Amin

- Fauzi Yusuf

- Putri Chairani Eyanoer

- Masrul Lubis

- Imelda Rey

13. Changes of cytokine levels and T cell surface molecules in patients with chronic hepatitis B and the association with functional cure

- Zhen Xu

- Ji‐zong Lin

- Ying‐fu Zeng

- Xiao‐hua Yang

- Zhe‐bin Wu

- Zhao‐xia Hu

- Qi‐yi Zhao

- Jing Liu

- Zhi‐liang Gao

14. Langzeittherapie der HBV-Infektion mit oralen Polymeraseinhibitoren

- F. van Bömmel

- T. Berg

15. The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for HBV?

- Lauke L Boeijen

- Michelle Spaan

- André Boonstra

16. Cytokines and Chemokines in HBV Infection

- Shihong Zhong

- Tianling Zhang

- Libo Tang

- Yongyin Li

17. Sustained Changes of Treg and Th17 Cells During Interferon-α Therapy in Patients with Chronic Hepatitis B

- Hao Feng

- Jie Yin

- Ya-Ping Han

- Xiao-Ying Zhou

- Su Chen

- Li Yang

- Jin-Rui Yan

- Guo-Xin Zhang

18. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study

- Shishu Zhu

- Hongfei Zhang

- Yi Dong

- Limin Wang

- Zhiqiang Xu

- Weiwei Liu

- Yu Gan

- Hongmei Tang

- Dawei Chen

- Fuchuan Wang

- Pan Zhao